The human microbiome is garnering research interest across the globe and industry is responding to the growing possibilities of therapeutic developments in a variety of ways, a key aspect of which is partnerships. The current state of play means emerging companies are often looking for specific expertise or experience in their partners, often influenced by the variety of approaches under different regulatory jurisdictions or financial structures.
Moderator: Mike Ward – Informa Pharma Insights
- Xavier Aldeguer Mauté – Goodgut
- Michel de Baar – MSD
- Eric de la Fortelle – Seventure
- Mariona Serra-Pagès – Goodgut